Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clyde B Schechter

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
JAMA|May 16, 2019
Effect of Restriction of the Number of Concurrently Open Records in an Electronic Health Record on Wrong-Patient Order Errors: A Randomized Clinical TrialJason S Adelman, Jo R Applebaum, Clyde B Schechter, et al.
Annals of Internal Medicine|November 19, 2009
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harmsJeanne S Mandelblatt, Kathleen A Cronin, Stephanie Bailey, et al.
Journal of the National Cancer Institute|May 30, 2014
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammographyNatasha K Stout, Sandra J Lee, Clyde B Schechter, et al.
Journal of the National Cancer Institute|July 29, 2021
Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-EffectivenessJennifer M Yeh, Kathryn P Lowry, Clyde B Schechter, et al.
Annals of Internal Medicine|August 23, 2016
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening OutcomesAmy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, et al.
Annals of Internal Medicine|July 16, 2014
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefitsIris Lansdorp-Vogelaar, Roman Gulati, Angela B Mariotto, et al.
Journal of the National Cancer Institute|September 27, 2014
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortalityDiego Munoz, Aimee M Near, Nicolien T van Ravesteyn, et al.
Journal of the National Cancer Institute|May 3, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast CancerJinani Jayasekera, Yisheng Li, Clyde B Schechter, et al.
JAMA Internal Medicine|August 26, 2024
Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast DensityNatasha K Stout, Diana L Miglioretti, Yu-Ru Su, et al.
Annals of Internal Medicine|March 2, 2026
Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk: Long-Term Health and Economic ConsiderationsAnna N A Tosteson, Natasha K Stout, Yu-Ru Su, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
JAMA|May 16, 2019
Effect of Restriction of the Number of Concurrently Open Records in an Electronic Health Record on Wrong-Patient Order Errors: A Randomized Clinical TrialJason S Adelman, Jo R Applebaum, Clyde B Schechter, et al.
Annals of Internal Medicine|November 19, 2009
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harmsJeanne S Mandelblatt, Kathleen A Cronin, Stephanie Bailey, et al.
Journal of the National Cancer Institute|May 30, 2014
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammographyNatasha K Stout, Sandra J Lee, Clyde B Schechter, et al.
Journal of the National Cancer Institute|July 29, 2021
Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-EffectivenessJennifer M Yeh, Kathryn P Lowry, Clyde B Schechter, et al.
Annals of Internal Medicine|August 23, 2016
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening OutcomesAmy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, et al.
Annals of Internal Medicine|July 16, 2014
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefitsIris Lansdorp-Vogelaar, Roman Gulati, Angela B Mariotto, et al.
Journal of the National Cancer Institute|September 27, 2014
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortalityDiego Munoz, Aimee M Near, Nicolien T van Ravesteyn, et al.
Journal of the National Cancer Institute|May 3, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast CancerJinani Jayasekera, Yisheng Li, Clyde B Schechter, et al.
JAMA Internal Medicine|August 26, 2024
Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast DensityNatasha K Stout, Diana L Miglioretti, Yu-Ru Su, et al.
Annals of Internal Medicine|March 2, 2026
Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk: Long-Term Health and Economic ConsiderationsAnna N A Tosteson, Natasha K Stout, Yu-Ru Su, et al.
Pageof 15